Aptorum Stock Price - APM

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aptorum Group Ltd APM NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 2.81 2.7355 3.29 3.29 2.81 20:00:00
Bid Price Ask Price Spread Spread % News
2.05 4.30 2.25 52.33% - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
179 16,543 $ 3.04 $ 50,337 52,375 1.66 - 33.28
Last Trade Time Type Quantity Stock Price Currency
16:11:20 formt 300 $ 2.81 USD

Aptorum Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 85.39M 30.39M $ -14.83M -0.53 - 30.39M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Aptorum News

Loading Messages....

Latest APM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.004.502.68663.4568,041-0.19-6.33%
1 Month4.414.501.663.0539,528-1.60-36.28%
3 Months14.0018.251.666.0830,476-11.19-79.93%
6 Months16.0018.251.666.6615,013-13.19-82.44%
1 Year13.9533.281.6610.6610,584-11.14-79.86%
3 Years15.8033.281.6611.039,192-12.99-82.22%
5 Years15.8033.281.6611.039,192-12.99-82.22%

Aptorum Description

Aptorum Group Ltd is a Hong Kong based pharmaceutical company currently in the preclinical stage, engaged in developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. The company is pursuing therapeutic and diagnostic projects in neurology, infectious diseases, gastroenterology, oncology and other disease areas. It also has projects focused on surgical robotics. The operating business segments are Therapeutics, and Non-Therapeutics segments. The company derives revenue from Healthcare service.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.